For example, in chronic myeloid leukemia (CML), MSCs protected CML cells from imatinib-induced cell death via the CXCL12/CXCR4 axis, which decreased caspase 3 activity [87]. Here, CXCL12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.